LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 63 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,913,675 | -58.1% | 8,784,813 | -9.4% | 7.17% | -52.7% |
| Q2 2023 | $30,846,000 | +30.7% | 9,700,000 | -3.0% | 15.16% | +23.8% |
| Q1 2023 | $23,600,000 | -32.0% | 10,000,000 | 0.0% | 12.24% | -17.4% |
| Q4 2022 | $34,700,000 | -52.7% | 10,000,000 | 0.0% | 14.82% | -37.1% |
| Q3 2022 | $73,300,000 | -15.4% | 10,000,000 | -24.7% | 23.57% | +1.1% |
| Q2 2022 | $86,600,000 | +29.1% | 13,282,181 | 0.0% | 23.32% | +24.3% |
| Q1 2022 | $67,075,000 | -34.8% | 13,282,181 | 0.0% | 18.76% | -11.3% |
| Q4 2021 | $102,804,000 | -47.7% | 13,282,181 | 0.0% | 21.15% | -26.9% |
| Q3 2021 | $196,576,000 | -8.9% | 13,282,181 | 0.0% | 28.95% | -0.7% |
| Q2 2021 | $215,703,000 | – | 13,282,181 | – | 29.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |